The leucocyte ascorbic acid content is widely used as a measure of tissue ascorbic acid status. Standard methods of analysis, however, isolate both leucocytes and platelets (buffy layer), with consequent overestimation, since platelet ascorbic acid is attributed to the leucocytes.
ascorbic acid content and the platelet: leucocyte ratio (r = 0'70, p<O·OOl). It is suggested that changes in the relative distribution of platelets and leucocytes in the blood will result in an apparent change in the 'leucocyte' ascorbic acid content regardless of any actual change in the ascorbic acid content of the cells.
shows the relation between the 'leucocyte' Methods Leucocytes were isolated by a modification of the method of Loh and Wilsons in that a Ficoll/sodium diatizoate mixture (Ficoll-Paque, Pharmacia Fine Chemicals) was used to sediment the erythrocytes instead of a methylcellulose/sodium metrizoate mixture.
Leucocyte numbers were measured in each leucocyte preparation and blood sample with an automated cell counter (Coulter model S, Coulter Electronics Ltd). Platelet numbers were measured in each leucocyte preparation with an automated thrombocyte counter (Coulter model C, Coulter Electronics Ltd).
The ascorbic acid content of the leucocyte preparations was measured by the dinitrophenylhydrazine method of Denson and Bowers. 3 Statistical analysis of the data was carried out using the methods outlined by Swinscow." sample (EDTA) was taken from each subject. In most cases, a second sample was taken a few days later. In all, 42 blood samples were obtained (20 from the healthy individuals and 22 from the patients). 'Leucocyte' ascorbic acid estimations and cell counts were begun within an hour of venesection.
Subjects
The investigation was carried out on subjects who were saturated with ascorbic acid in order to minimise any real variations in the ascorbic acid content of the cells. Both healthy individuals and patients were included in the study for comparison.
Fourteen healthy individuals aged 19 to 60 (mean 30) years were given oral supplements of ascorbic acid (I g twice a day).
Eleven patients aged 36 to 65 (mean 50) years were receiving mega dose ascorbic acid therapy (2' 5 g three times a day). Nine of these patients had neoplastic disorders, one had rheumatoid arthritis, Results and the other multiple sclerosis.
After at least five days on the supplements a blood Figure 1 252
Ascorbic acid status is usually assessed by measuring the leucocyte ascorbic acid content-2 but the procedures used to isolate the leucocytes-' also isolate the platelets." Platelets contain a substantial amount of ascorbic acid, which is therefore erroneously attributed to the leucocytes. This results in an overestimate of the leucocyte ascorbic acid content,"
We report on the relation between apparent leucocyte ('leucocyte') ascorbic acid content and the relative numbers of platelets and leucocytes in the leucocyte preparation (buffy layer). We suggest that this relationship demonstrates that the role of platelets in the interpretation of ascorbic acid status is more important than was previously realised.
Comparison of platelet: leucocyte ratio in the leucocyte preparation with the ratio in the corresponding blood sample for 10 healthy individuals preparation does reflect that in blood but that some platelet enrichment occurs, probably as a result of some of the leucocytes sedimenting with the erythrocytes.
A negative correlation was observed (Fig. 2 ) between the 'leucocyte' ascorbic acid content and the leucocyte count of the corresponding blood samples (r = -0·60, p<O·OOI). The significance of this finding is discussed later. ascorbic acid content and the relative numbers of platelets and leucocytes, expressed as a ratio, in the leucocyte preparations. There is a significant increase in the 'leucocyte' ascorbic acid content with increasing platelet contribution for both the healthy individuals (r = 0'67, p<O-01) and the patients (r = 0'75, p<O·OOI). Indeed, the relationship is so similar for both groups that the combined data show a significant correlation (r = 0'70, p<O·OOI). A linear regression analysis was used to calculate the line of best fit for the combined data ( Fig. 1 ). An estimate of the true leucocyte ascorbic acid content in the absence of the platelet contribution can be obtained by extrapolation of this line to a zero platelet: leucocyte ratio. This suggests that the variation in platelet contribution is responsible for up to a threefold overestimate in the leucocyte ascorbic acid content.
There is a wide variation in the platelet: leucocyte ratio even for the healthy individuals (34-75). To determine whether this variation is a true reflection of the ratio in blood, or an artifact produced by the sedimentation procedure, the ratio in the leucocyte preparation was compared with that in the corresponding blood sample. The results for 10 of the healthy individuals (Table) show a highly significant correlation (r =0'97, p<O·OOI) but the ratio is approximately 20 %higher in the leucocyte preparations. This confirms that the ratio in the leucocyte 
Discussion
Leucocyte ascorbic acid estimation was initially used in the assessment of vitamin deficiency in scurvy. 7 Since then it has been generally applied to the assessment and monitoring of ascorbic acid status in a wide variety of conditions, including neoplasia," infection," surgery,10 myocardial infarction.P and burns.P
The standard methods of estimating the leucocyte ascorbic acid contents 4 give an overestimate because platelet ascorbic acid also is measured and attributed to the leucocytes." This would not present a serious problem if the relative platelet contribution, and hence degree of overestimation, was constant. The results we have presented suggest that this is not the case; even in healthy individuals, there is a substantial variation in the relative platelet numbers with corresponding changes in the 'leucocyte' ascorbic acid content. Further support for this finding comes from the observation that the degree of overestimation of the leucocyte ascorbic acid content is lower than normal in thrombocytopenia, whereas it is higher than normal in thrombocythaemia."
The variation in the relative platelet numbers in the leucocyte preparations has been shown to be due largely to differences in the relative numbers of platelets and leucocytes in the blood.
Any real changes in the ascorbic acid content of leucocytes or platelets would be superimposed upon artifactual changes caused by variation in the relative platelet and leucocyte numbers. The results suggest that the apparent changes caused by differences in relative numbers of platelets and leucocytes are more important than was previously realised since a substantial proportion of the observed variation in 'leucocyte' ascorbic acid content (variance for Fig. 1 = 0'49) can be explained in this way. Therefore we suggest that such methods of estimating 'leucocyte' ascorbic acid content should be interpreted with caution and that the relative numbers of platelets and leucocytes should be taken into account when assessing differences in ascorbic acid status. This would be especially important when comparing groups with different distributions of platelets and leucocytes or when monitoring conditions in which the distribution changes with time.
Numerous workers studying 'leucocyte' ascorbic acid content in a variety of conditions have reported a negative correlation between the 'leucocyte' ascorbic acid content and the leucocyte count. For example, such changes have been observed in healthy individuals,1314 in leukaemic patients.s and after surgical trauma.P The aetiology of this negative correlation is unclear, although several Evans, Currie, and Campbell hypotheses have been put forward. Loh and Wilson 13 and Vallancets suggested that the available ascorbic acid is distributed among available leucocytes, MacLennan and Hamilton" have postulated as the cause a migration of leucocytes rich in ascorbic acid to sites of infection or infarction. Barton and Roath" have proposed a dilution of the leucocyte ascorbic acid by increased numbers of immature, ascorbic acid depleted leucocytes as an alternative explanation of the negative correlation observed, for example, in chronic myelogenous leukaemia.
We suggest that a further hypothesis for these observations is possible. The negative correlation could be due to an artifact resulting from changes in the relative distribution of platelets and leucocytes. Leucocytosis, unless associated with a similar degree of thrombocytosis, will result in a decrease in the number of platelets relative to leucocytes, which will cause an apparent fall in the 'leucocyte' ascorbic acid content. The fact that we have also shown a negative correlation between the 'leucocyte' ascorbic acid content and the leucocyte count in our group of subjects gives some support to this hypothesis as we have shown that a substantial part of the observed variation in the 'leucocyte' ascorbic acid can be explained by such an artifact. Furthermore, these subjects were saturated with ascorbic acid, which would minimise any real variations in the ascorbic acid content of the cells.
H is interesting to speculate how much of the observed fall in 'leucocyte' ascorbic acid content after infection," surgery.l" or myocardial infarction'! can be attributed to this artifact because of associated leucocytosis.
